Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial

BACKGROUND: We conducted a multicenter randomized study of adjuvant S-1 administration schedules for surgically treated pathological stage IB-IIIA non-small cell lung cancer patients. METHODS: Patients receiving curative surgical resection were centrally randomized to arm A (4 weeks of oral S-1 and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Hata, Yoshinobu, Kiribayashi, Takaharu, Kishi, Kazuma, Nagashima, Makoto, Nakayama, Takefumi, Ikeda, Shingo, Kadokura, Mitsutaka, Ozeki, Yuichi, Otsuka, Hajime, Murakami, Yoshitaka, Takagi, Keigo, Iyoda, Akira
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5575891/
https://ncbi.nlm.nih.gov/pubmed/28851314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3584-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires